In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailTerns CEO Amy Burroughs on oral GLP-1 offeringAmy Burroughs, Terns Pharma CEO, joins 'Closing Bell Overtime' to talk progress in its GLP-1 drug development.

---

Persons: Amy Burroughs Organizations: Terns Pharma